Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
van der Hout AH, van den Ouweland AM, van der Luijt RB, Gille HJ, Bodmer D, Brüggenwirth H, Mulder IM, van der Vlies P, Elfferich P, Huisman MT, ten Berge AM, Kromosoeto J, Jansen RP, van Zon PH, Vriesman T, Arts N, Lange MB, Oosterwijk JC, Meijers-Heijboer H, Ausems MG, Hoogerbrugge N, Verhoef S, Halley DJ, Vos YJ, Hogervorst F, Ligtenberg M, Hofstra RM. van der Hout AH, et al. Among authors: oosterwijk jc. Hum Mutat. 2006 Jul;27(7):654-66. doi: 10.1002/humu.20340. Hum Mutat. 2006. PMID: 16683254
The HLA class III subregion is responsible for an increased breast cancer risk.
de Jong MM, Nolte IM, de Vries EG, Schaapveld M, Kleibeuker JH, Oosterom E, Oosterwijk JC, van der Hout AH, van der Steege G, Bruinenberg M, Boezen HM, Te Meerman GJ, van der Graaf WT. de Jong MM, et al. Among authors: oosterwijk jc. Hum Mol Genet. 2003 Sep 15;12(18):2311-9. doi: 10.1093/hmg/ddg245. Epub 2003 Jul 22. Hum Mol Genet. 2003. PMID: 12915440
The decision evaluation scales.
Stalmeier PF, Roosmalen MS, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Moog U, Hoogerbrugge N, van Daal WA. Stalmeier PF, et al. Among authors: oosterwijk jc. Patient Educ Couns. 2005 Jun;57(3):286-93. doi: 10.1016/j.pec.2004.07.010. Patient Educ Couns. 2005. PMID: 15893210 Free article.
No increased susceptibility to breast cancer from combined CHEK2 1100delC genotype and the HLA class III region risk factors.
de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WT, Oosterom E, Bruinenberg M, Steege Gv, Oosterwijk JC, van der Hout AH, Boezen HM, Schaapveld M, Kleibeuker JH, de Vries EG. de Jong MM, et al. Among authors: oosterwijk jc. Eur J Cancer. 2005 Aug;41(12):1819-23. doi: 10.1016/j.ejca.2005.04.035. Eur J Cancer. 2005. PMID: 16043347
Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?
van der Velde NM, Mourits MJ, Arts HJ, de Vries J, Leegte BK, Dijkhuis G, Oosterwijk JC, de Bock GH. van der Velde NM, et al. Among authors: oosterwijk jc. Int J Cancer. 2009 Feb 15;124(4):919-23. doi: 10.1002/ijc.24038. Int J Cancer. 2009. PMID: 19035463
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.
Gómez García EB, Oosterwijk JC, Timmermans M, van Asperen CJ, Hogervorst FB, Hoogerbrugge N, Oldenburg R, Verhoef S, Dommering CJ, Ausems MG, van Os TA, van der Hout AH, Ligtenberg M, van den Ouweland A, van der Luijt RB, Wijnen JT, Gille JJ, Lindsey PJ, Devilee P, Blok MJ, Vreeswijk MP. Gómez García EB, et al. Among authors: oosterwijk jc. Breast Cancer Res. 2009;11(1):R8. doi: 10.1186/bcr2223. Epub 2009 Feb 6. Breast Cancer Res. 2009. PMID: 19200354 Free PMC article.
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.
Mohammadi L, Vreeswijk MP, Oldenburg R, van den Ouweland A, Oosterwijk JC, van der Hout AH, Hoogerbrugge N, Ligtenberg M, Ausems MG, van der Luijt RB, Dommering CJ, Gille JJ, Verhoef S, Hogervorst FB, van Os TA, Gómez García E, Blok MJ, Wijnen JT, Helmer Q, Devilee P, van Asperen CJ, van Houwelingen HC. Mohammadi L, et al. Among authors: oosterwijk jc. BMC Cancer. 2009 Jun 29;9:211. doi: 10.1186/1471-2407-9-211. BMC Cancer. 2009. PMID: 19563646 Free PMC article.
Body weight and risk of breast cancer in BRCA1/2 mutation carriers.
Manders P, Pijpe A, Hooning MJ, Kluijt I, Vasen HF, Hoogerbrugge N, van Asperen CJ, Meijers-Heijboer H, Ausems MG, van Os TA, Gomez-Garcia EB, Brohet RM; HEBON; van Leeuwen FE, Rookus MA. Manders P, et al. Breast Cancer Res Treat. 2011 Feb;126(1):193-202. doi: 10.1007/s10549-010-1120-8. Epub 2010 Aug 21. Breast Cancer Res Treat. 2011. PMID: 20730487
189 results